Enzyme (MLN): Uses, Supply and Risks

Enzyme (MLN) is the official token of Enzyme Finance, a project building infrastructure for tokenized funds and on-chain investment strategies. Enzyme’s tools are designed for asset managers, institutions and DeFi builders who need to create and manage on-chain portfolios or financial products. The project describes offerings such as vault-as-a-service and financial instruments.

That describes the broader Enzyme platform, but it does not by itself explain every role MLN has within it. Public information available here confirms that MLN is the project’s official token, but does not specify a full list of token-holder rights, governance powers, or how fees may be paid or distributed. Avoid assuming that holding MLN gives you a claim on a fund’s assets or income. Those details depend on the specific product and its terms.

Enzyme Finance focuses on infrastructure for managing tokenized funds and on-chain strategies. Its intended users include professional asset managers, institutions and developers working in DeFi. The platform’s stated product areas include vault-as-a-service and financial instruments, which are used to build and operate on-chain financial offerings.

MLN is identified as Enzyme’s official token, but public sources do not establish exactly how it is used in each product. In particular, it does not confirm whether MLN is required to use a vault, used for governance, or connected to fees. Check current Enzyme documentation and the terms of any product before relying on a particular token utility. A token’s association with a financial platform does not make it equivalent to ownership of the platform, its funds, or assets managed through it.

MLN was launched in 2017. The reported circulating and total supply are both about 3.28 million tokens, and no maximum supply is specified. This means the reported circulating amount matches the reported total, but it should not be read as a guarantee that supply can never change; check current token documentation for the issuance policy.

As of 2026-11-05, MLN was reported at about $1.32, with a market capitalization and fully diluted valuation of roughly $4.3 million each. These figures are snapshots and can change quickly. The token has also experienced substantial price movement over its history, so a recent price or market value is not a reliable guide to future performance. This information is not a price forecast or a recommendation to buy or sell.

MLN has been issued on Ethereum, Polygon and Arbitrum. It is not listed here as the native token of any of those networks, so check which network a wallet, exchange or Enzyme product supports before transferring it. Tokens with the same ticker can exist on different networks, and sending an asset through an unsupported network can make it difficult or impossible to recover.

Like other crypto assets, MLN carries risks including sharp price changes, loss of access through a compromised device or misplaced recovery phrase, and errors when selecting a network or token contract. Enzyme products can also involve smart-contract, operational and underlying-asset risks; those are separate from the risks of holding MLN itself. If you choose to hold the token, use a wallet that supports the correct network, protect your recovery phrase offline, and verify transaction details before signing. Never share your recovery phrase with anyone.